According to Pharvaris's latest financial reports the company's current EPS (TTM) is -$2.20. In 2022 the company made an earnings per share (EPS) of -$2.42 a decrease over its 2021 EPS that were of -$2.07.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.20 | -9.16% |
2022 | -$2.42 | 17.22% |
2021 | -$2.07 | 111.11% |
2020 | -$0.98 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -0.87% | ๐บ๐ธ USA |